OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ASND

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Ascendis Pharma A/S (ASND) Earnings Date & Reports

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ASND is expected to report earnings to fall 19.52% to -65 cents per share on November 13

Ascendis Pharma A/S ASND Stock Earnings Reports

Q3'25

Est.

$-0.66

Q2'25

Beat

by $0.45

Q1'25

Missed

by $0.11

Q4'24

Beat

by $0.34

Q3'24

Missed

by $0.18

The last earnings report on August 07 showed earnings per share of -81 cents, beating the estimate of -126 cents. With 39.47K shares outstanding, the current market capitalization sits at 11.60B.

View a ticker or compare two or three

Compare

ASND

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ASND
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ASND showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of drug candidates

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Tuborg Boulevard 12

Phone

+45 70222244

Employees

879

Web

https://www.ascendispharma.com